Reports from Urmia University of Medical Sciences Add New Study Findings to Research in Central Nervous System Agents (Carrier-Free Inhalable Dry Microparticles of Celecoxib: Use of the Electrospraying Technique).

Předmět:	CENTRAL nervous system CELECOXIB CYCLOOXYGENASE 2 inhibitors
Zdroj:	Medical Letter on the CDC & FDA; 7/14/2023, p1408-1408, 1p
Abstrakt:	Celecoxib (CLX), a selective COX-2 inhibitor, may have beneficial effects in COVID-19-induced inflammatory storms." Keywords for this news article include: Urmia University of Medical Sciences, Pharmaceuticals, Analgesics, Pathogenesis, COX-2 Inhibitors, Celecoxib Therapy, Drugs and Therapies, Health and Medicine, Central Nervous System Agents. Keywords: Analgesics; COX-2 Inhibitors; Celecoxib Therapy; Central Nervous System Agents; Drugs and Therapies; Health and Medicine; Pathogenesis; Pharmaceuticals EN Analgesics COX-2 Inhibitors Celecoxib Therapy Central Nervous System Agents Drugs and Therapies Health and Medicine Pathogenesis Pharmaceuticals 1408 1408 1 07/10/23 20230714 NES 230714 2023 JUL 14 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Researchers detail new data in central nervous system agents. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu